![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Ralph Schimmer, MD, MBA speaks to Alice Greenway, Commissioning Editor of Future Virology. Ralph has been Chief Medical Officer and Head Global Medical & Scientific Affairs for Centralized and Point of Care Solutions within the Roche Diagnostics division since May 2014. Between 2012 and 2016, Ralph was the Roche coordinator of the Innovative Medicines Initiative’s (IMI) project Eu2P, a public-private partnership with a consortium of seven European universities, 15 pharmaceutical companies and the European and French Medicines Agencies. The Commissioning Editor of Future Virology, Alice Greenway, talks to Schimmer about the role that Roche Diagnostics plays in the development of tailored diagnostic solutions for complex viruses as well as the launch of the new Elecsys® Zika IgG assay.
Disclaimer
The opinions expressed in this interview are those of the interviewee and do not necessarily reflect the views of Future Medicine Ltd.
Financial & competing interests disclosure
R Schimmer is an employee of Roche Diagnostics International Ltd. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.